Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

Zentalis Pharmaceuticals, Inc. financial statements

Zentalis Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue067.4M0000014.0K
Cost of revenue739.0K1.29M1.39M1.43M544.0K160.0K111.0K
Gross profit-739.0K67.4M-1.39M-1.43M-544.0K-160.0K-111.0K14.0K
Research and development107.3M167.8M189.6M172.7M175.6M84.9M38.4M18.9M
Selling, general and administrative37.7M87.1M59.4M54.6M40.9M33.9M8.46M4.88M
Operating income-152.8M-191.2M-299.5M-227.3M-216.5M-118.8M-46.8M-23.8M
Depreciation and amortization739.0K1.29M1.39M1.43M544.0K160.0K111.0K51.0K
EBITDA-152.1M-189.9M-298.1M-225.9M-216.0M-118.6M-46.7M-23.7M
Interest expense2.58M110.0M2.23M1.20M0
Income before tax-136.6M-165.7M-292.9M-237.6M-166.4M-118.1M-46.4M-23.4M
Income tax442.0K177.0K-601.0K-469.0K-297.0K444.0K15.0K4.00K
Net income-137.1M-165.8M-292.2M-236.8M-158.7M-117.8M-45.7M-21.1M
Earnings per share, basic-1.91-2.33-4.47-4.48-3.72-4.19-0.77-1.17
Earnings per share, diluted-1.91-2.33-4.47-4.48-3.72-4.19-8.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents36.0M33.9M28.0M43.1M59.7M55.0M67.2M25.2M
Short-term investments209.9M318.0M454.9M394.3M280.2M283.6M
Receivables05.00M07.04M4.00K417.0K140.0K917.0K
Inventory-7.04M-4.44M
Current assets253.2M386.1M496.7M451.9M350.8M345.1M68.9M26.7M
Property, plant and equipment2.77M4.70M5.82M7.71M8.15M1.10M501.0K260.0K
Goodwill03.74M3.74M3.74M3.74M3.74M3.74M
Total assets289.0M430.3M551.7M539.3M454.5M365.6M87.5M41.0M
Accounts payable7.21M7.44M14.9M11.2M11.6M8.66M4.29M3.43M
Current liabilities36.6M52.7M69.4M56.6M43.9M28.6M14.9M6.21M
Total debt39.6M42.6M45.8M47.3M45.9M2.00M2.48M
Total liabilities72.8M93.2M114.3M105.3M90.0M32.2M19.1M8.69M
Shareholders' equity216.2M337.2M437.3M433.8M364.0M308.6M-73.3M24.8M
Shares outstanding69.1M71.3M70.8M59.3M45.5M41.0M59.4M18.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-125.2M-170.9M-207.8M-163.8M-154.1M-86.8M-39.1M-24.3M
Capital spending0-221.0K-583.0K-2.55M-6.11M-758.0K-352.0K-227.0K
Free cash flow-125.2M-171.1M-208.4M-166.3M-160.2M-87.6M-39.5M-24.5M
Cash from investing131.6M176.6M-44.5M-114.2M-18.1M-284.8M-352.0K-227.0K
Cash from financing-4.28M108.0K237.3M261.0M178.5M360.4M81.8M9.47M
Share buybacks-9.98M00261.0M-1.15K346.2M81.9M9.47M
Change in cash2.09M5.81M-15.0M-16.9M6.31M-11.2M42.3M-15.0M